FT516 and IL2 With Enoblituzumab for Ovarian Cancer

Clinical trial NCT04630769 · COMPLETED

Trial details

NCT number: NCT04630769
Sponsor: Masonic Cancer Center, University of Minnesota
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Fallopian Tube Adenocarcinoma Primary Peritoneal Cavity Cancer

Start date: 2021-04-02
Primary completion: 2022-01-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.